V. Effelsberg

Chronic lower-dose relaxin administration protects from arrhythmia in experimental myocardial infarction due to anti-inflammatory and anti-fibrotic properties.

T. Beiert, J. Trebicka, G. Nickenig, 2018, International journal of cardiology.

Relaxin reduces susceptibility to post-infarct atrial fibrillation in mice due to anti-fibrotic and anti-inflammatory properties.

T. Beiert, J. Trebicka, G. Nickenig, 2017, Biochemical and biophysical research communications.

treatment with spironolactone reduces adhesion formation after abdominal surgery and inhibits mesothelial to mesenchymal transition

S. Wehner, J. Kalff, Verena Effelsberg, 2020 .